Related Experiment Video
Updated: Jun 6, 2025
16:49
Multifocal Electroretinograms
Published on: December 4, 2011
18.2K
Mimickers of hydroxychloroquine retinal toxicity.
Peter Jones1, Gagan Kalra1, Mayss Al-Sheikh2
1UPMC Vision Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Clinical & Experimental Ophthalmology
|December 3, 2024
Summary
Hydroxychloroquine (HCQ) retinopathy can mimic other eye conditions, making diagnosis difficult. This review highlights key differences to help identify HCQ retinal toxicity accurately.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Background:
- Hydroxychloroquine (HCQ) retinopathy presents a diagnostic challenge due to its varied clinical manifestations.
- Bull's eye maculopathy is characteristic but shares features with other retinal conditions.
- Accurate differentiation is crucial for patient management and preventing vision loss.
Purpose of the Study:
- To review hydroxychloroquine (HCQ) retinopathy.
- To discuss conditions that mimic HCQ retinopathy.
- To emphasize clinical and ancillary distinctions for accurate diagnosis.
Main Methods:
- Literature review of HCQ retinopathy and its differentials.
- Analysis of clinical presentations and imaging findings.
- Identification of key diagnostic features.
Main Results:
- HCQ retinopathy shares similarities with drug toxicities, inherited retinal disorders, and systemic retinopathies.
- Clinical and ancillary diagnostic data can be confusing.
- Specific features aid in distinguishing HCQ toxicity.
Conclusions:
- Differentiating HCQ retinopathy from mimickers requires careful evaluation.
- Key clinical and ancillary distinctions are essential for accurate diagnosis by ophthalmologists and primary care physicians.
- Early and accurate diagnosis of HCQ retinopathy is vital for appropriate patient care.
